DL-Alanyl-DL-leucine
CAS : 1999-42-4
Ref. 3D-BAA99942
1g | Arrêté | ||
5g | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté | ||
2500mg | Arrêté |
Informations sur le produit
- 2-(2-Aminopropanamido)-4-methylpentanoic acid
- 2-(2-Aminopropanoylamino)-4-methylpentanoic acid
- <span class="text-smallcaps">DL</smallcap>-Alanyl-<smallcap>DL</span>-leucine
- <span class="text-smallcaps">DL</smallcap>-Leucine, N-<smallcap>DL</span>-alanyl-
- Alanineleucine
- Alanylleucine
- DL-Alanine-DL-leucine
- H-DL-Ala-DL-Leu-OH
- Leucine, N-<span class="text-smallcaps">DL</smallcap>-alanyl-, <smallcap>DL</span>-
- Leucine, alanyl-
- Voir d'autres synonymes
- NSC 89664
- DL-Leucine, N-DL-alanyl-
- Leucine, N-DL-alanyl-, DL-
DL-Alanyl-DL-leucine (ALA) is a dipeptide that is involved in many biochemical processes and is a potential biomarker for chronic kidney disease. ALA is synthesized from the amino acids alanine and leucine. It has been shown to be an important molecule in the regulation of renal function and can be used as a potential biomarker for acute kidney injury. ALA also plays an important role in fatty acid metabolism, where it can serve as an energy source or act as a precursor for lipid synthesis.